TAMARIND EXTRACT INHIBITS CYTOCHROME P450 (CYP3A4 ISOZYME) - AN IN VITRO STUDY
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i7.25767Keywords:
Tamarind extract, Cytochrome P450 enzymes, Herb-drug interaction, InhibitionAbstract
Objective: The aim of the present study was to analyze the effect of the aqueous fruit pulp extract of Tamarindus indica L. (tamarind extract) on cytochrome P 450 isoform CYP3A4.
Methods: Tamarind extract at different concentrations from 5 to 100 μg/ml was examined for its inhibitory property toward cytochrome P 450 isoform CYP3A4. The various concentrations of tamarind extract, potassium phosphate buffer, CYP450 reagent, and substrate 7-Benzyloxy-4- trifluoromethylcoumarin were added to a 96-well plate. The mixtures were preincubated for 20 min at room temperature. The reaction was started by a mixture of free constituted substrate and NADP+ and incubated at room temperature for 30–60 min. The reaction was stopped by Tris-HCl buffer, pH 10.5. The fluorescent intensities of the products were measured by PerkinElmer Enspire fluorescence reader using an excitation and emission wavelength of 405 nm and 460 nm, respectively. Inhibitory concentration (IC50) was calculated by plotting concentrations of tamarind extract against the corresponding percentage inhibition.
Results: All the tested concentrations of extract except 5 μg/ml showed good inhibition against CYP3A4 in a dose-dependent manner. The IC50 value of tamarind for CYP3A4 inhibitory activity was found to be 27.89 μg/ml.
Conclusion: T. indica aqueous fruit pulp extract exhibited an inhibitory effect on CYP34A, thereby indicating the possibilities of herb-drug interaction if these extracts are coadministered with the prescribed drugs that are metabolized by CYP3A4.
Downloads
References
Anzenbacher P, Anzenbacherova E. Review cytochrome P450 and metabolism of xenobiotics. Cell Mol Life Sci 2001;58:737-47.
Marks BD, Larson BR. Miniaturization and automation of cytochrome P450 inhibition Assay. Acta Pharm Sin B 2012;2:137-45.
Uddin G, Rauf A, Siddiqui BS, Shah S. Preliminary comparative phytochemical screen-ing of Diospyros lotus Stewart. Mid J Sci Res 2011;10:78-81.
Razali N, Aziz AA, Lim CY, Junit SM. The investigation into the effects of an antioxidant-rich extract of Tamarindus indica leaf on antioxidant enzyme activities, oxidative stress and gene expression profiles in HepG2 cells. Peer J 2015;3:e1292.
Ranjan R, Swarup D, Patra RC, Chandra V. Tamarindus indica L and Moringa oleiferaoleifera M. Extract administration ameliorates fluoride toxicity in rabbits. Indian J Exp Biol 2009;47:900-5.
Ebifa-Othieno E, Mugisha A, Nyeko P, Kabasa JD. Knowledge, attitudes, and practices in tamarind (Tamarindus indica L) use and conservation in Eastern Uganda. J Ethnobiol Ethnomed 2017;13:5.
Anannarukan N, Niwattisaiwong N, Warisnoicharoen W, Winitthana T, Pramyothin P, Chaichantipyuth C, et al. Inhibition of human cytochrome P450 in vitro by Phyllanthus amarus and Phyllanthus emblica aqueous extracts. Thai J Pharm Sci 2012;36:135-43.
Zhang JW, Liu Y, Cheng J, Li W, Ma H, Liu HT, et al. Inhibition of human liver cytochrome P450 by star fruit juice. J Pharm Pharm Sci 2007;10:496-503.
Ashour ML, Youssef FS, Gad HA, Wink M. Inhibition of cytochrome P450 (CYP3A4) activity by extracts from 57 plants used in traditional Chinese medicine (TCM). Pharm Mag 2017;13:300-8.
Thomford NE, Dzobo K, Adu F, Chirikure S, Wonkam A, Dandara C.Bush mint (Hyptis suaveolens) and spreading hogweed (Boerhavia diffusa) medicinal plant extracts differentially affect activities of CYP1A2, CYP2D6, and CYP3A4 enzymes. J Ethnopharmacol 2018;211:58-69.
Higdon JV, Frei B. Tea catechins and polyphenols: Health effects, metabolism and antioxidant functions. Crit Rev Food Sci Nutr 2010;43:89-143.
Chinni S, Dubala A, Kosaraju J, Khatwal RB, Satish Kumar MN, Kannan E. Effect of crude extract of Eugenia jambolana Lam. on human cytochrome P450 enzymes. Phytother Res 2014;28:1731-4.
Sripanidkulchai B, Tattawasart U, Laupatarakasem P, Vinitketkumneun U, Sripanidkulchai K, Furihata C, et al. Antimutagenic and anticarcinogenic effects of Phyllanthus amarus. Phytomedicine 2002;9:26-32.
Muto S, Fujita K, Yamazaki Y, Kamataki T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res 2001;479:197-206.
Winitthana T, Niwattisaiwong N, Patarapanich C, Tantisira MH, Lawanprasert S. In vitro inhibitory effects of asiaticoside and madecassoside on human cytochrome P450. Toxicol In Vitro 2011;25:890-6.
Marks BD, Smith RW, Braun HA, Goossens TA, Christenson M, Ozers MS, et al. A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic Vivid P450 substrate Assay. Drug Dev Technol 2002;1:73-81.
Marks BD, Larson BR. Miniaturization and automation of cytochrome P450 inhibition assay. Available from: http://www.tools.invitrogen. com/downloads/Miniaturization Automation Cytochrome P450.pdf. [Last cited on 2011].
Kumar KB, Kuttan R. Inhibition of drug metabolizing enzymes (cytochrome P450) in vitro as well as in vivo by Phyllanthus amarus Schum and Thonn. Biol Pharm Bull 2006;29:1310-3.
Ashwini S, Ezhilarasan D, Anitha R, Cytotoxic effect of Caralluma fimbriata against human colon cancer cells. Pharm J 2017;9:98-101.
Ashwini S, Anitha R. Anti-hyperglycaemic activity of Caralluma fimbriata-An in vitro approach. Pharm Magaz 2017;13:S499-544.
Anitha R, Geetha RV, Lakshmi T, Nallanayagam M. Edible fruits - nature’s gift for diabetic patients - a comprehensive review. Int J Pharm Sci Rev Res 2011;9:170-80.
Sarah S, Dhanraj G, Anitha R. Anxiety and aromatherapy- a review. J Pharm Biosci 2016;7:267-73.
Ismail MY. Herb-drug interactions and patient counselling. Int J Pharm Pharm Sci 2009;1:151-61.
Patil L, Kulkarni K, Khanvilkar V, Kadam V. In vitro evaluation of herb-drug interactions: A review. Int J Pharm Pharm Sci 2014;6:9-12.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
